Influences of Female Sex and Reproductive Hormones on Physiological Aspects of Heat Acclimation

NCT ID: NCT05292170

Last Updated: 2024-08-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

27 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-10-01

Study Completion Date

2024-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Women are often understudied in thermal physiology research, leaving recommendations for Soldier safety and performance in hot conditions based largely on data collected in men. Female sex hormones estradiol and progesterone clearly have non-reproductive physiological effects, including influences on thermoregulatory and cardiovascular function. However, mechanisms of differing physiological adaptations to repeated heat exposure (i.e., heat acclimation) as a function of reproductive hormone status have yet to be investigated in a systematic way. Understanding possible sex differences in adaptation or mechanisms for adaptation during heat acclimation is important to ultimately optimize interventions to maximize soldier health and safety during training and deployment in the heat. Our goals in the present study are to evaluate physiological and biophysical responses to a standard heat acclimation protocol in a group of young, healthy men and women. Thirty individuals (n=10 males, n=10 women with a low hormonal status (i.e. early follicular phase), n=10 women with a high hormonal status (i.e. midluteal phase)) will complete 10 consecutive days of exercise (treadmill walking: 3.1 mph/2% grade) in the heat (40°C /40% relative humidity) up to 3hr per day. Changes in core temperature, heart rate, and sex hormones will be assessed to examine differences in thermoregulatory response to heat acclimation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heat Stress, Exertional

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Males

10 consecutive day heat acclimation in males

Group Type EXPERIMENTAL

Heat acclimation

Intervention Type OTHER

10 consecutive days of heat acclimation

Females + high hormones

10 consecutive day heat acclimation in females with high hormonal dose

Group Type EXPERIMENTAL

Heat acclimation

Intervention Type OTHER

10 consecutive days of heat acclimation

Females + low hormones

10 consecutive day heat acclimation in females with low hormonal dose

Group Type EXPERIMENTAL

Heat acclimation

Intervention Type OTHER

10 consecutive days of heat acclimation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Heat acclimation

10 consecutive days of heat acclimation

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* • Males and females, age 18-40 y (17 y for active duty military)

* Eumenorrheic females (menstrual cycle length between 24-35 days) or females taking oral contraceptives
* In good health as determined by OMSO (Office of Medical Support and Oversight) General Medical Clearance and willing to report all medications and dietary supplements (i.e. cold medication, Tylenol. Aleve) to the PI and OMSO.
* Passed his/her most recent Army Combat Fitness Test (ACFT) (military volunteers only) or exercise at least 2 times per week (civilian volunteers)
* Willing to not exercise, or drink alcoholic beverages for 24 hours before each testing session
* Willing to not consume caffeine 12 hours prior to any testing sessions
* Willing to refrain from additional moderate to strenuous physical activity throughout testing period
* Males and females with BMI \<30

Exclusion Criteria

* • Females who are pregnant or planning to become pregnant during the study

* Females utilizing implantable contraception (intrauterine device, implantable bar)
* Tested positive for COVID-19 within the past 30 days.
* Taking prescription or over the counter medication, other than a contraceptive (unless approved by OMSO and Principal Investigator (PI))
* Tobacco users, or anyone who has used tobacco within the last four months
* Physical problems/injuries that would affect walking or running on a treadmill
* Allergy to skin adhesive
* Heart, lung, kidney, muscle, endocrine, or nerve disorder(s)
* History of heat intolerance or orthostatic intolerance
* Diagnosed and/or treated for fluid/electrolyte imbalance within the last 30 days
* History of obstructive disease of the gastrointestinal tract including (but not limited to) diverticulosis, diverticulitis and inflammatory bowel disease, peptic ulcer disease, Crohn's disease, ulcerative colitis.
* Scheduled MRI during testing
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

United States Army Research Institute of Environmental Medicine

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

U.S. Army Research Institute of Environmental Medicine

Natick, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

21-07Hc

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.